Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BTF3 pseudogene 1 (BTF3P1), also referred to as HUMBTFA or lambda h16, is a genomic sequence classified as a pseudogene—a non-functional remnant of the gene encoding Basic transcription factor 3 (BTF3)[3][4]. Unlike BTF3, which is a multifunctional transcription factor required for RNA polymerase II-mediated gene expression and has been implicated as an oncogene in various cancers[1][2], BTF3P1 does not code for a functional protein and is not considered a receptor, enzyme, or direct therapeutic target. Pseudogenes such as BTF3P1 may occasionally have regulatory DNA or RNA roles, but no such functions or disease associations have been documented for BTF3P1 in current scientific literature[4]. If a therapeutic or research context seeks the target "BTF3P1," this is likely a misidentification; only **BTF3** itself is a functional transcription factor and a potential therapeutic or biomarker target in cancer and other disease models[1][2][3]. Pseudogenes naming can cause confusion, so confirm focus on the parent gene (BTF3) for scientific or clinical applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BTF3 pseudogene 1 (BTF3P1).